The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Alexza Pharmaceuticals Inc | COM | 015384100 | 2,048 | 399,999 | SH | SOLE | 399,999 | 0 | 0 | ||
Anacor Pharmaceuticals Inc | COM | 032420101 | 17,107 | 1,610,856 | SH | SOLE | 1,610,856 | 0 | 0 | ||
A P Pharma Inc | COM | 00202J203 | 3,038 | 9,067,700 | SH | SOLE | 9,067,700 | 0 | 0 | ||
BioCryst Pharmaceuticals Inc | COM | 09058V103 | 15,875 | 2,180,656 | SH | SOLE | 2,180,656 | 0 | 0 | ||
Biodel Inc | COM | 09064M105 | 4,037 | 1,281,592 | SH | SOLE | 1,281,592 | 0 | 0 | ||
Chelsea Therapeutics International Ltd | COM | 163428105 | 7,525 | 2,516,870 | SH | SOLE | 2,516,870 | 0 | 0 | ||
DBV Technologies | COM | F2927N109 | 5,094 | 480,000 | SH | SOLE | 480,000 | 0 | 0 | ||
Dyax Corp | COM | 26746E103 | 28,514 | 4,156,508 | SH | SOLE | 4,156,508 | 0 | 0 | ||
GTx Inc | COM | 40052B108 | 1,013 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
GW Pharmaceuticals | COM | 36197T103 | 14,527 | 837,800 | SH | SOLE | 837,800 | 0 | 0 | ||
Hyperion Therapeutics Inc | COM | 44915N101 | 5,685 | 217,571 | SH | SOLE | 217,571 | 0 | 0 | ||
Ironwood Pharmaceuticals Inc | COM | 46333X108 | 21,312 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | ||
Keryx Biopharmaceuticals Inc | COM | 492515101 | 20,672 | 2,048,773 | SH | SOLE | 2,048,773 | 0 | 0 | ||
Neurocrine Biosciences Inc | COM | 64125C109 | 14,391 | 1,271,303 | SH | SOLE | 1,271,303 | 0 | 0 | ||
Ophthotech Corporation | COM | 683745103 | 1,560 | 52,500 | SH | SOLE | 52,500 | 0 | 0 | ||
TESARO Inc | COM | 881569107 | 10,116 | 261,130 | SH | SOLE | 261,130 | 0 | 0 | ||
Threshold Pharmaceuticals Inc | COM | 885807206 | 3,181 | 684,000 | SH | SOLE | 684,000 | 0 | 0 | ||
Vanda Pharmaceuticals Inc | COM | 921659108 | 5,377 | 491,075 | SH | SOLE | 491,075 | 0 | 0 |